Trial · NCT03532932
Outcomes13
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants Stratified by Treatment Patterns Associated With Biologics Agents Use or Non-biological Therapy in Participants With Moderate to Severe UC and CD | From 2 years before enrollment up to Month 12 after enrollment (up to 3 years) | FAS included those participants who signed the informed consent form and were analyzed in the study. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants Stratified by Location of Disease | Within 1 year prior to Baseline (Visit 1) | FAS included those participants who signed the informed consent form and were analyzed in the study. Here, overall number of participants analyzed signified participants who were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants Stratified by Disease Severity | At Visit 1 (Baseline), Visit 2 (6 months), Visit 3 (12 months) of prospective period | FAS included those participants who signed the informed consent form and were analyzed in the study. Here, overall number of participants analyzed signified participants who were evaluable for this outcome measure and number analyzed signifies participants who were evaluable at specified visits. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants Based on Usage of Methods for Documentation of Disease Activity in Routine Practice | From Baseline Visit (Day 1) up to 12 months | FAS included those participants who signed the informed consent form and were analyzed in the study. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Assessments Using Different Methods in Participants With UC and CD Disease Activity | From Baseline Visit (Day 1) up to 12 months | FAS included those participants who signed the informed consent form and were analyzed in the study. | assessments | MEAN |
| SECONDARY | UC Participants: Percentage of Participants Who Achieved Combined Clinical and Endoscopic Remission Based on Mayo Index | At Visit 1 (Baseline), Visit 2 (6 months), Visit 3 (12 months) of prospective period | FAS included those participants who signed the informed consent form and were analyzed in the study. | percentage of participants | NUMBER |
| SECONDARY | CD Participants: Percentage of Participants Who Achieved Clinical Remission Based on HBI | At Visit 1 (Baseline), Visit 2 (6 months), Visit 3 (12 months) of prospective period | FAS included those participants who signed the informed consent form and were analyzed in the study. | percentage of participants | NUMBER |
| SECONDARY | Number of Participants With at Least One Episode of Failure of Biological or Non-biological Therapy | From 2 years before enrollment up to Month 12 after enrollment (up to 3 years) | FAS included those participants who signed the informed consent form and were analyzed in the study. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants Who Needed Treatment Adjustments Based on Disease Activity Assessment | From 2 years before enrollment up to Month 12 after enrollment (up to 3 years) | FAS included those participants who signed the informed consent form and were analyzed in the study. Here, overall number of participants analyzed signified participants who were evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Percentage of Participants Stratified by Achieving the Treatment Goals | From 2 years before enrollment up to Month 12 after enrollment (up to 3 years) | FAS included those participants who signed the informed consent form and were analyzed in the study. Here, overall number of participants analyzed signified participants who were evaluable for this outcome measure and number analyzed signifies participants who were evaluable for given categories. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Based on Challenges of Implementing a T2T Strategy in UC and CD Participants in Real Clinical Practice | From 2 years before enrollment up to Month 12 after enrollment (up to 3 years) | FAS included those participants who signed the informed consent form and were analyzed in the study. Here, overall number of participants analyzed signified participants who were evaluable for this outcome measure. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Based on Hospitalizations Due to Complications, IBD Related Surgeries, and Disability Determination in Participants With Moderate to Severe UC and CD | From 2 years before enrollment up to Month 12 after enrollment (up to 3 years) | FAS included those participants who signed the informed consent form and were analyzed in the study. | percentage of participants | NUMBER |
| SECONDARY | Percentage of Participants Based on Surgical Treatment by Indications and Type of Surgeries | From 2 years before enrollment up to Month 12 after enrollment (up to 3 years) | FAS included those participants who signed the informed consent form and were analyzed in the study. Here, number analyzed signifies participants who were evaluable for given categories. | percentage of participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03532932/outcomes